导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 1.75% | 1179/2282 |
| 近一周 | -1.90% | 1581/2314 |
| 近一月 | -2.25% | 1184/2307 |
| 近一季 | -2.63% | 924/2292 |
| 近半年 | -1.26% | 1224/2290 |
| 近一年 | 5.17% | 1071/2265 |
| 近两年 | 37.90% | 1194/2173 |
| 近三年 | 16.48% | 1226/2101 |
| 成立以来 | 117.59% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-0.63% 1263/2333 |
9.28% 1111/2331 |
- - |
- - |
| 2025 | 16.02% 1389/2338 |
-3.20% 2135/2326 |
2.50% 822/2347 |
16.26% 1248/2344 |
0.58% 1105/2338 |
| 2024 | 5.45% 971/2331 |
-2.85% 1401/2322 |
1.65% 404/2326 |
9.06% 1007/2317 |
-2.09% 1363/2331 |
| 2023 | -23.91% 2012/2323 |
-3.74% 2096/2290 |
-10.68% 2141/2303 |
-5.19% 1158/2318 |
-6.64% 1858/2330 |
| 2022 | -20.25% 1337/2294 |
-21.91% 1959/2227 |
15.29% 161/2269 |
-18.30% 2135/2294 |
8.41% 115/2300 |
| 2021 | -0.82% 1665/2202 |
-1.71% 1146/2009 |
14.45% 506/2060 |
-9.93% 1834/2103 |
-2.11% 1918/2208 |
| 2020 | 61.00% 482/2082 |
-2.47% 1283/1861 |
24.26% 458/1950 |
13.98% 468/2010 |
16.55% 457/2031 |
| 2019 | 63.94% 114/1973 |
26.74% 743/3054 |
-1.26% 1804/3201 |
19.41% 27/1861 |
9.70% 503/1886 |
| 2018 | -24.52% 1325/1913 |
- - |
- - |
- - |
-14.01% 2637/2977 |
| 2017 | 24.29% 161/1885 |
- - |
- - |
- - |
- - |
| 2016 | -24.48% 780/1510 |
- - |
- - |
- - |
- - |
| 2015 | 22.37% 219/849 |
- - |
- - |
- - |
- - |
| 2014 | 18.59% 84/147 |
- - |
- - |
- - |
- - |
| 2013 | 11.19% 42/99 |
- - |
- - |
- - |
- - |
| 2012 | 12.06% 55/459 |
- - |
- - |
- - |
- - |
| 2011 | -19.28% 90/392 |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 前海开源医疗健康A | 1.3491 | 47.46% |
| 前海开源医疗健康C | 1.3376 | 47.43% |
| 中信建投医改混合C | 1.6114 | 38.85% |
| 中信建投医改混合A | 1.9799 | 35.61% |
| 国投瑞银医疗保健混合C | 1.1936 | 27.48% |
| 国投瑞银医疗保健混合A | 1.2077 | 26.73% |
| 浦银安盛医疗健康混合A | 1.3477 | 24.27% |
| 浦银安盛医疗健康混合C | 1.3207 | 23.97% |
| 华夏医疗健康混合A | 1.9620 | 23.63% |
| 易方达供给改革混合 | 8.0699 | 23.63% |
| 中银蓝筹混合 VS. 德邦优化A(770001) |